Company intelligence / Profile preview

Innovita Research

Vilnius, Lithuaniainnovitaresearch.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Innovita Research develops cell-based therapies for aging-related degenerative diseases, cancer immunotherapy using xenogeneic differentiation antigens, leucocyte-based anti-infectious/tissue-protective technologies, T-cell therapies for autoimmune disorders, and offers pre-clinical trial services. The company has published scientific papers and patented several technologies but does not appear to have advanced programs in late-stage clinical trials or commercial drug approvals as of May 2025. Recent news highlights research on injectable heart failure prevention post-MI and nanoparticle targeting of glioblastoma in mice.

Therapeutic areas
OncologyImmunologyNeurology
Modalities
Cell-based therapiesProteins (natural and recombinant)ExosomesPolyantigenic anticancer vaccinesMesenchymal stem cells
Industry
Biotech
02

Drug pipeline

13 assets

xenogeneic polyantigenic vaccine

Preclinical

12 more assets in the full pipeline.

Beyond the preview

Go deeper on Innovita Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovita Research.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call